Key regions: Australia, United States, India, Europe, China
The Digestive & Intestinal Remedies (Pharmacies) market in G7 is experiencing significant growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.
Customer preferences: Consumers in the G7 countries are increasingly seeking digestive and intestinal remedies from pharmacies. This shift in preference can be attributed to the convenience and accessibility offered by pharmacies. Customers value the expertise of pharmacists who can provide advice and recommendations on the best remedies for their digestive and intestinal issues. Additionally, pharmacies often carry a wide range of products, allowing customers to choose from different brands and formulations.
Trends in the market: One major trend in the Digestive & Intestinal Remedies market in G7 is the growing demand for natural and herbal remedies. Customers are becoming more conscious of the ingredients in the products they consume and are opting for remedies that are perceived as more natural and gentle on their digestive systems. This trend is driving the development of new products that incorporate herbal extracts and natural ingredients. Another trend in the market is the increasing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for the digestive system. They are believed to improve gut health and provide relief from digestive issues. The demand for probiotic supplements and foods is rising as consumers become more aware of their potential health benefits.
Local special circumstances: Each country in the G7 has its own unique circumstances that contribute to the development of the Digestive & Intestinal Remedies market. For example, in the United States, the high prevalence of digestive disorders such as irritable bowel syndrome and acid reflux has led to a significant demand for remedies. In Japan, the aging population and the traditional diet, which includes fermented foods, have created a favorable environment for the growth of the market.
Underlying macroeconomic factors: The growing Digestive & Intestinal Remedies market in G7 can also be attributed to underlying macroeconomic factors. Rising disposable incomes in these countries have increased consumers' purchasing power, allowing them to spend more on healthcare and wellness products. Additionally, the increasing prevalence of digestive and intestinal disorders, such as gastrointestinal infections and food intolerances, is driving the demand for remedies. In conclusion, the Digestive & Intestinal Remedies (Pharmacies) market in G7 is experiencing growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors. Customers are increasingly turning to pharmacies for their digestive and intestinal remedies, driven by convenience and the expertise of pharmacists. The market is witnessing trends such as the demand for natural and herbal remedies, as well as the popularity of probiotics. Each country in the G7 has its own unique circumstances that contribute to the development of the market, and underlying macroeconomic factors such as rising disposable incomes and the increasing prevalence of digestive disorders also play a role.
Data coverage:
The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.Modeling approach:
Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.Additional notes:
The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
